Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.000
+0.044 (4.62%)
At close: Nov 20, 2024, 4:00 PM
1.030
+0.030 (3.00%)
After-hours: Nov 20, 2024, 7:44 PM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $53.99 million as of November 21, 2024. Its market cap has decreased by -0.00% in one year.
Market Cap
53.99M
Enterprise Value
107.28M
1-Year Change
-0.00%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $53.99M, a decrease of -89.50%. That is a compound annual growth rate of -51.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 53.99M | -9.54% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aadi Bioscience | 52.99M |
| Shattuck Labs | 52.75M |
| Precision BioSciences | 52.52M |
| Exagen | 52.16M |
| Prelude Therapeutics | 51.84M |
| Kronos Bio | 51.24M |
| vTv Therapeutics | 50.87M |
| Cytosorbents | 50.85M |